This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2a7o

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2a7o" size="450" color="white" frame="true" align="right" spinBox="true" caption="2a7o" /> '''Solution Structure of the hSet2/HYPB SRI do...)
Line 1: Line 1:
-
[[Image:2a7o.gif|left|200px]]<br />
+
[[Image:2a7o.gif|left|200px]]<br /><applet load="2a7o" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2a7o" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2a7o" />
caption="2a7o" />
'''Solution Structure of the hSet2/HYPB SRI domain'''<br />
'''Solution Structure of the hSet2/HYPB SRI domain'''<br />
==Overview==
==Overview==
-
The phosphorylation state of the C-terminal repeat domain (CTD) of the, largest subunit of RNA polymerase II changes as polymerase transcribes a, gene, and the distinct forms of the phospho-CTD (PCTD) recruit different, nuclear factors to elongating polymerase. The Set2 histone, methyltransferase from yeast was recently shown to bind the PCTD of, elongating RNA polymerase II by means of a novel domain termed the, Set2-Rpb1 interacting (SRI) domain. Here, we report the solution structure, of the SRI domain in human Set2 (hSRI domain), which adopts a left-turned, three-helix bundle distinctly different from other structurally, characterized PCTD-interacting domains. NMR titration experiments mapped, the binding surface of the hSRI domain to helices 1 and 2, and Biacore, binding studies showed that the domain binds preferably to [Ser-2 +, Ser-5]-phosphorylated CTD peptides containing two or more heptad repeats., Point-mutagenesis studies identified five residues critical for PCTD, binding. In view of the differential effects of these point mutations on, binding to different CTD phosphopeptides, we propose a model for the hSRI, domain interaction with the PCTD.
+
The phosphorylation state of the C-terminal repeat domain (CTD) of the largest subunit of RNA polymerase II changes as polymerase transcribes a gene, and the distinct forms of the phospho-CTD (PCTD) recruit different nuclear factors to elongating polymerase. The Set2 histone methyltransferase from yeast was recently shown to bind the PCTD of elongating RNA polymerase II by means of a novel domain termed the Set2-Rpb1 interacting (SRI) domain. Here, we report the solution structure of the SRI domain in human Set2 (hSRI domain), which adopts a left-turned three-helix bundle distinctly different from other structurally characterized PCTD-interacting domains. NMR titration experiments mapped the binding surface of the hSRI domain to helices 1 and 2, and Biacore binding studies showed that the domain binds preferably to [Ser-2 + Ser-5]-phosphorylated CTD peptides containing two or more heptad repeats. Point-mutagenesis studies identified five residues critical for PCTD binding. In view of the differential effects of these point mutations on binding to different CTD phosphopeptides, we propose a model for the hSRI domain interaction with the PCTD.
==About this Structure==
==About this Structure==
-
2A7O is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2A7O OCA].
+
2A7O is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2A7O OCA].
==Reference==
==Reference==
Line 17: Line 16:
[[Category: Guan, Z.]]
[[Category: Guan, Z.]]
[[Category: Li, M.]]
[[Category: Li, M.]]
-
[[Category: Phatnani, H.P.]]
+
[[Category: Phatnani, H P.]]
[[Category: Sage, H.]]
[[Category: Sage, H.]]
[[Category: Zhou, P.]]
[[Category: Zhou, P.]]
Line 30: Line 29:
[[Category: sri domain]]
[[Category: sri domain]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:47:01 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:24:31 2008''

Revision as of 14:24, 21 February 2008


2a7o

Drag the structure with the mouse to rotate

Solution Structure of the hSet2/HYPB SRI domain

Overview

The phosphorylation state of the C-terminal repeat domain (CTD) of the largest subunit of RNA polymerase II changes as polymerase transcribes a gene, and the distinct forms of the phospho-CTD (PCTD) recruit different nuclear factors to elongating polymerase. The Set2 histone methyltransferase from yeast was recently shown to bind the PCTD of elongating RNA polymerase II by means of a novel domain termed the Set2-Rpb1 interacting (SRI) domain. Here, we report the solution structure of the SRI domain in human Set2 (hSRI domain), which adopts a left-turned three-helix bundle distinctly different from other structurally characterized PCTD-interacting domains. NMR titration experiments mapped the binding surface of the hSRI domain to helices 1 and 2, and Biacore binding studies showed that the domain binds preferably to [Ser-2 + Ser-5]-phosphorylated CTD peptides containing two or more heptad repeats. Point-mutagenesis studies identified five residues critical for PCTD binding. In view of the differential effects of these point mutations on binding to different CTD phosphopeptides, we propose a model for the hSRI domain interaction with the PCTD.

About this Structure

2A7O is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1., Li M, Phatnani HP, Guan Z, Sage H, Greenleaf AL, Zhou P, Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17636-41. Epub 2005 Nov 28. PMID:16314571

Page seeded by OCA on Thu Feb 21 16:24:31 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools